|
gptkbp:instance_of
|
gptkb:legal_case
|
|
gptkbp:advocacy
|
patient rights
policy reform
anti-opioid organizations
|
|
gptkbp:clinical_trial
|
not reached
|
|
gptkbp:community_feedback
|
support groups
|
|
gptkbp:community_health
|
addiction prevention
opioid epidemic
opioid education
|
|
gptkbp:community_impact
|
families affected
|
|
gptkbp:community_outreach
|
awareness campaigns
|
|
gptkbp:community_support
|
local organizations
|
|
gptkbp:consequences
|
regulatory changes
corporate responsibility
future lawsuits
|
|
gptkbp:court
|
gptkb:opioid_manufacturers
gptkb:state_government
state court
|
|
gptkbp:damage
|
financial compensation
|
|
gptkbp:defense
|
pharmaceutical regulations
|
|
gptkbp:economic_impact
|
state budgets
|
|
gptkbp:economic_policy
|
gptkb:healthcare_reform
addiction treatment funding
|
|
gptkbp:expert_analysis
|
economic effects
|
|
gptkbp:focus
|
gptkb:accountability
|
|
gptkbp:funding
|
rehabilitation services
|
|
gptkbp:future_cases
|
precedent setting
|
|
gptkbp:has_meetings
|
gptkb:Legislative_body
|
|
gptkbp:healthcare
|
increased burden
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
State v. Opioid Manufacturers
|
|
gptkbp:impact
|
public health
|
|
gptkbp:initiatives
|
opioid prevention programs
|
|
gptkbp:international_response
|
media spotlight
|
|
gptkbp:involves
|
opioid crisis
|
|
gptkbp:is_a_basis_for
|
consumer protection laws
|
|
gptkbp:is_accountable_to
|
corporate practices
|
|
gptkbp:is_debated_in
|
deceptive marketing practices
|
|
gptkbp:judicial_review
|
court decisions
|
|
gptkbp:jurisdiction
|
state jurisdiction
|
|
gptkbp:legal_framework
|
tort law
|
|
gptkbp:legal_issue
|
appeals process
|
|
gptkbp:legal_outcome
|
financial settlements
increased scrutiny
|
|
gptkbp:legal_representation
|
attorneys general
|
|
gptkbp:legislation
|
opioid crisis response
|
|
gptkbp:litigation_strategy
|
class action lawsuits
|
|
gptkbp:major_city
|
billions of dollars
ongoing discussions
funding for treatment programs
|
|
gptkbp:media_coverage
|
high-profile case
|
|
gptkbp:outcome
|
gptkb:Roman_settlement
|
|
gptkbp:political_position
|
regulation of pharmaceuticals
|
|
gptkbp:precedent
|
pharmaceutical accountability
other opioid lawsuits
|
|
gptkbp:public_health_funding
|
state budgets
|
|
gptkbp:public_perception
|
divided
|
|
gptkbp:public_reaction
|
increased awareness
|
|
gptkbp:related_cases
|
multi-district litigation
|
|
gptkbp:related_to
|
addiction treatment
|
|
gptkbp:research
|
opioid effects
|
|
gptkbp:responds_to
|
opioid crisis management
|
|
gptkbp:social_issues
|
drug addiction
|
|
gptkbp:state_resources
|
allocated for treatment
|
|
gptkbp:was_a_demonstration_of
|
internal documents
|
|
gptkbp:witnesses
|
gptkb:healthcare_professionals
victims of addiction
|
|
gptkbp:year
|
gptkb:2019
|
|
gptkbp:bfsParent
|
gptkb:Minnesota's_attorney_general
|
|
gptkbp:bfsLayer
|
6
|